133 related articles for article (PubMed ID: 35764196)
21. ICAM-1 expression by lung cancer cell lines: effects of upregulation by cytokines on the interaction with LAK cells.
Melis M; Spatafora M; Melodia A; Pace E; Gjomarkaj M; Merendino AM; Bonsignore G
Eur Respir J; 1996 Sep; 9(9):1831-8. PubMed ID: 8880099
[TBL] [Abstract][Full Text] [Related]
22. 7-O-geranylquercetin-induced autophagy contributes to apoptosis via ROS generation in human non-small cell lung cancer cells.
Wang EX; Zou BY; Shi L; Du LY; Zhu YY; Jiang YM; Ma XD; Kang XH; Wang CY; Zhen YH; Sun LD
Life Sci; 2017 Jul; 180():102-113. PubMed ID: 28495516
[TBL] [Abstract][Full Text] [Related]
23. D-Amino Acid Analogues of the Antimicrobial Peptide CDT Exhibit Anti- Cancer Properties in A549, a Human Lung Adenocarcinoma Cell Line.
Evans HG; Guthrie JW; Jujjavarapu M; Hendrickson N; Eitel A; Park Y; Garvey J; Newman R; Esckilsen D; Heyl DL
Protein Pept Lett; 2017; 24(7):590-598. PubMed ID: 28641565
[TBL] [Abstract][Full Text] [Related]
24. Anticancer effects of α-Bisabolol in human non-small cell lung carcinoma cells are mediated via apoptosis induction, cell cycle arrest, inhibition of cell migration and invasion and upregulation of P13K/AKT signalling pathway.
Wu S; Peng L; Sang H; Ping Li Q; Cheng S
J BUON; 2018; 23(5):1407-1412. PubMed ID: 30570866
[TBL] [Abstract][Full Text] [Related]
25. Luteoloside induces G
Zhou M; Shen S; Zhao X; Gong X
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631
[TBL] [Abstract][Full Text] [Related]
26. Selective apoptosis-inducing activity of synthetic hydrocarbon-stapled SOS1 helix with d-amino acids in H358 cancer cells expressing KRAS
Xu LL; Li CC; An LY; Dai Z; Chen XY; You QD; Hu C; Di B
Eur J Med Chem; 2020 Jan; 185():111844. PubMed ID: 31706640
[TBL] [Abstract][Full Text] [Related]
27. Licochalcone B inhibits growth and induces apoptosis of human non-small-cell lung cancer cells by dual targeting of EGFR and MET.
Oh HN; Lee MH; Kim E; Yoon G; Chae JI; Shim JH
Phytomedicine; 2019 Oct; 63():153014. PubMed ID: 31323446
[TBL] [Abstract][Full Text] [Related]
28. Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway.
Wang R; Ma L; Weng D; Yao J; Liu X; Jin F
Oncol Rep; 2016 May; 35(5):3075-83. PubMed ID: 26987028
[TBL] [Abstract][Full Text] [Related]
29. Pemetrexed Disodium Heptahydrate Induces Apoptosis and Cell-cycle Arrest in Non-small-cell Lung Cancer Carrying an EGFR Exon 19 Deletion.
Mohiuddin M; Kasahara K
Anticancer Res; 2021 Jun; 41(6):2963-2977. PubMed ID: 34083287
[TBL] [Abstract][Full Text] [Related]
30. Growth arrest and apoptosis via caspase activation of dioscoreanone in human non-small-cell lung cancer A549 cells.
Hansakul P; Aree K; Tanuchit S; Itharat A
BMC Complement Altern Med; 2014 Oct; 14():413. PubMed ID: 25342427
[TBL] [Abstract][Full Text] [Related]
31. Synergistic effect of the pro-apoptosis peptide kla-TAT and the cationic anticancer peptide HPRP-A1.
Hu C; Chen X; Huang Y; Chen Y
Apoptosis; 2018 Feb; 23(2):132-142. PubMed ID: 29397453
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the mechanism and apoptotic pathway induced by 4β cinnamido linked podophyllotoxins against human lung cancer cells A549.
Kamal A; Nayak VL; Bagul C; Vishnuvardhan MV; Mallareddy A
Apoptosis; 2015 Nov; 20(11):1518-29. PubMed ID: 26386574
[TBL] [Abstract][Full Text] [Related]
33. Discovery of a novel protein kinase C activator from Croton tiglium for inhibition of non-small cell lung cancer.
Wang Y; Tang C; Yao S; Lai H; Li R; Xu J; Wang Q; Fan XX; Wu QB; Leung EL; Ye Y; Yao X
Phytomedicine; 2019 Dec; 65():153100. PubMed ID: 31648127
[TBL] [Abstract][Full Text] [Related]
34. Identification of Flavone Derivative Displaying a 4'-Aminophenoxy Moiety as Potential Selective Anticancer Agent in NSCLC Tumor Cells.
Mobbili G; Romaldi B; Sabbatini G; Amici A; Marcaccio M; Galeazzi R; Laudadio E; Armeni T; Minnelli C
Molecules; 2023 Apr; 28(7):. PubMed ID: 37050002
[TBL] [Abstract][Full Text] [Related]
35. Development of pharmaceutically scalable inhaled anti-cancer nanotherapy - Repurposing amodiaquine for non-small cell lung cancer (NSCLC).
Parvathaneni V; Kulkarni NS; Chauhan G; Shukla SK; Elbatanony R; Patel B; Kunda NK; Muth A; Gupta V
Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111139. PubMed ID: 32600728
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive analysis of circular RNA profiling in AZD9291-resistant non-small cell lung cancer cell lines.
Chen T; Luo J; Gu Y; Huang J; Luo Q; Yang Y
Thorac Cancer; 2019 Apr; 10(4):930-941. PubMed ID: 30883029
[TBL] [Abstract][Full Text] [Related]
37. HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells.
Muralidharan R; Mehta M; Ahmed R; Roy S; Xu L; Aubé J; Chen A; Zhao YD; Herman T; Ramesh R; Munshi A
Sci Rep; 2017 Aug; 7(1):9694. PubMed ID: 28855578
[TBL] [Abstract][Full Text] [Related]
38. Targeting Adenine Nucleotide Translocase-2 (ANT2) to Overcome Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer.
Jang JY; Kim YG; Nam SJ; Keam B; Kim TM; Jeon YK; Kim CW
Mol Cancer Ther; 2016 Jun; 15(6):1387-96. PubMed ID: 26883272
[TBL] [Abstract][Full Text] [Related]
39. Anticancer effects of ginsenoside Rk3 on non-small cell lung cancer cells: in vitro and in vivo.
Duan Z; Deng J; Dong Y; Zhu C; Li W; Fan D
Food Funct; 2017 Oct; 8(10):3723-3736. PubMed ID: 28949353
[TBL] [Abstract][Full Text] [Related]
40. [FOXC1 Knockdown Reverses Gefitinib Resistance in Non-small Cell Lung Cancer].
Peng C; Li P; Yang M; Chen D; Huang Y
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):538-547. PubMed ID: 34334155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]